6/13 Food and Drug Administration--Press Releases

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Food and Drug Administration--Press Releases FDA Requests Labeling Change for Leukotriene Modifiers June 12, 2009 at 3:05 pm The U.S. Food and Drug Administration today provided further updated safety information on a class of asthma drugs known as leukotriene modifiers. FDA has requested that manufacturers include a precaution in the drug prescribing information (drug labeling) regarding neuropsychiatric events (behavior, mood changes) that have been reported in some persons taking montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo and Zyflo CR).   This email was sent to skripayura.drugsnews@blogger.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.